178 related articles for article (PubMed ID: 23839185)
1. Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature.
Shetty S; Ahmed AR
J Drugs Dermatol; 2013 Jun; 12(6):672-7. PubMed ID: 23839185
[TBL] [Abstract][Full Text] [Related]
2. Refractory childhood pemphigoid successfully treated with rituximab.
Fuertes I; Luelmo J; Leal L; Romaní J; Sánchez S; Mascaró JM
Pediatr Dermatol; 2013; 30(5):e96-7. PubMed ID: 23278674
[TBL] [Abstract][Full Text] [Related]
3. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
Matsukura S; Knowles SR; Walsh S; Shear NH
Arch Dermatol; 2012 Jun; 148(6):734-9. PubMed ID: 22351790
[TBL] [Abstract][Full Text] [Related]
4. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
Shetty S; Ahmed AR
J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
[TBL] [Abstract][Full Text] [Related]
5. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
[No Abstract] [Full Text] [Related]
6. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
Nigam R; Levitt J
J Drugs Dermatol; 2012 May; 11(5):622-5. PubMed ID: 22527431
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up.
Ahmed AR; Shetty S; Kaveri S; Spigelman ZS
J Am Acad Dermatol; 2016 Apr; 74(4):700-8.e3. PubMed ID: 26851830
[TBL] [Abstract][Full Text] [Related]
8. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab.
Ahmed AR; Shetty S
Autoimmun Rev; 2015 Apr; 14(4):323-31. PubMed ID: 25499920
[TBL] [Abstract][Full Text] [Related]
12. Refractory bullous pemphigoid with fatal outcome in a young patient.
Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
[No Abstract] [Full Text] [Related]
13. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
Front Immunol; 2018; 9():248. PubMed ID: 29520266
[TBL] [Abstract][Full Text] [Related]
14. Durable remission of pemphigus with a fixed-dose rituximab protocol.
Heelan K; Al-Mohammedi F; Smith MJ; Knowles S; Lansang P; Walsh S; Shear NH
JAMA Dermatol; 2014 Jul; 150(7):703-8. PubMed ID: 24500264
[TBL] [Abstract][Full Text] [Related]
15. Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities.
Cho HH; Jin SP; Chung JH
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):186-91. PubMed ID: 23356542
[TBL] [Abstract][Full Text] [Related]
16. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
Wang TS; Tsai TF
Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of rituximab treatment in Indian pemphigus patients.
Kanwar AJ; Tsuruta D; Vinay K; Koga H; Ishii N; Dainichi T; Hashimoto T
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e17-23. PubMed ID: 22176540
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
Reguiaï Z; Tchen T; Perceau G; Bernard P
Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
[TBL] [Abstract][Full Text] [Related]
19. Remission Time after Rituximab Treatment for Autoimmune Bullous Disease: A Proposed Update Definition.
Iranzo P; Pigem R; Giavedoni P; Alsina-Gibert M
Skin Pharmacol Physiol; 2015; 28(5):255-6. PubMed ID: 26021780
[TBL] [Abstract][Full Text] [Related]
20. Severe bullous pemphigoid in an infant--successful treatment with rituximab.
Schulze J; Bader P; Henke U; Rose MA; Zielen S
Pediatr Dermatol; 2008; 25(4):462-5. PubMed ID: 18789089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
